Efficacy and safety of paricalcitol in patients undergoing hemodialysis: a meta-analysis
Yang Liu,1 Ling-Yun Liu,2 Ye Jia,1 Mei-Yan Wu,1 Yan-Yan Sun,3 Fu-Zhe Ma1 1Department of Nephrology, The First Hospital of Jilin University, Changchun, China; 2Department of Andrology, The First Hospital of Jilin University, Changchun, China; 3Department of Nephrology, The Fourth Hospital of Jilin U...
Main Authors: | Liu Y, Liu LY, Jia Y, Wu MY, Sun YY, Ma FZ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-03-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-and-safety-of-paricalcitol-in-patients-undergoing-hemodialysi-peer-reviewed-article-DDDT |
Similar Items
-
Comparative efficacy and safety of paricalcitol versus vitamin D receptor activators for dialysis patients with secondary hyperparathyroidism: a meta-analysis of randomized controlled trials
by: Yifeng Xie, et al.
Published: (2017-08-01) -
Selective vitamin D receptor activator Paricalcitol and its potential benefits in hemodialysis patients with secondary hyperparathyroidism
by: L. V. Egshatyan
Published: (2022-06-01) -
Comparison of Paricalcitol (I.V) and Alfacalcidol (I.V) in Treatment of Secondary Hyperparathyroidism (SHPT) in Hemodialysis Patients
by: Mansoor Abbas Qaisar, et al.
Published: (2020-12-01) -
Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study—A Comparison
by: Jacek Zawierucha, et al.
Published: (2019-02-01) -
Effect of Early and Delayed Commencement of Paricalcitol in Combination with Enalapril on the Progression of Experimental Polycystic Kidney Disease
by: Priyanka S. Sagar, et al.
Published: (2021-10-01)